[Advances on efficacy and mechanisms of acid fibroblast growth factor for promoting injured tissue repair]. [PDF]
Zhu F +5 more
europepmc +1 more source
[Research progress on the mechanisms and optimization strategies of mesenchymal stem cell-derived exosomes in the treatment of liver diseases]. [PDF]
Li XR, Niu B, Zhang LY.
europepmc +1 more source
[Advances in basic and experimental diagnostic research on liver diseases in 2025]. [PDF]
Chen DB, Yang RF, Chen HS.
europepmc +1 more source
[Efficacy of intravenous thrombolysis beyond 4.5 to 24 hours in patients with isolated posterior circulation acute ischemic stroke]. [PDF]
Wang J +8 more
europepmc +1 more source
[Changes in hepatic phase Ⅱ detoxification enzymes and their mechanism in metabolic associated steatohepatitis (MASH) induced by MCD diet in mice]. [PDF]
Gao JQ +6 more
europepmc +1 more source
[Gut microbiota-associated metabolites with drug-induced liver injury]. [PDF]
Gao WK +5 more
europepmc +1 more source
[Gut-vascular axis in Kawasaki disease: short-chain fatty acid-mediated immune regulation and therapeutic targets]. [PDF]
Wang SD, Liu F.
europepmc +1 more source
[The role of polyunsaturated fatty acid lipid peroxidation in ferroptosis after intracerebral hemorrhage: a review of mecha-nisms and therapeutic implications]. [PDF]
Guo M, Zhao G, Cai Z, Zhang Z, Zhou J.
europepmc +1 more source
[Advances in research on the mechanisms of reactive oxygen species in platelet activation and thrombosis]. [PDF]
Shen RY, Xu KL, Qiao JL, Fu P.
europepmc +1 more source
[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]
Wu ST, Lu XL.
europepmc +1 more source

